SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-021339
Filing Date
2024-06-27
Accepted
2024-06-27 08:45:14
Documents
23
Period of Report
2024-06-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20240507_8k.htm   iXBRL 8-K 28181
2 EXHIBIT 99.1 ex_669041.htm EX-99.1 65347
7 acclaim3.jpg GRAPHIC 3726
8 aclaim1.jpg GRAPHIC 4356
9 aclaim2.jpg GRAPHIC 4337
10 diab.jpg GRAPHIC 28733
11 g01.jpg GRAPHIC 50367
12 genp.jpg GRAPHIC 4174
13 lun.jpg GRAPHIC 37213
14 our.jpg GRAPHIC 34992
  Complete submission text file 0001437749-24-021339.txt   474122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20240627.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20240627_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20240627_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20240627_pre.xml EX-101.PRE 11584
26 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20240507_8k_htm.xml XML 2824
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 241075538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)